2
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Secondary Polycythemia May Be an Early Clinical Manifestation of Multiple Myeloma: A Case Report

, , , , &
Pages 325-330 | Received 23 Mar 2024, Accepted 23 Jul 2024, Published online: 30 Jul 2024

References

  • Wang S, Xu L, Feng J, et al. Prevalence and incidence of multiple myeloma in urban area in china: a national population-based analysis. Front Oncol. 2020;9:1513. doi:10.3389/fonc.2019.01513
  • Liu W, Liu J, Song Y, et al. Union for China leukemia investigators of the Chinese society of clinical oncology, union for China lymphoma investigators of the Chinese society of clinical oncology. Mortality of lymphoma and myeloma in China, 2004–2017: an observational study. J Hematol Oncol. 2019;12(1):22. doi:10.1186/s13045-019-0706-9
  • Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060. doi:10.1056/NEJMra1011442
  • Cowan AJ, Green DJ, Kwok M, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464–477. doi:10.1001/jama.2022.0003
  • Pearson TC. Diagnosis and classification of erythrocytoses and thrombocytoses. Baillieres Clin Haematol. 1998;11(4):695–720. doi:10.1016/s0950-3536(98)80035-8
  • Lee SG, Lim G, Cho SY, et al. JAK2 mutation-negative secondary erythrocytosis in smoldering plasma cell myeloma: a case study and review of the literature. Acta Haematol. 2011;126(3):169–171. doi:10.1159/000328996
  • Hutchison EJ, Taverna JA, Yu Q, et al. Polycythaemia: an unusual presentation of multiple myeloma. BMJ Case Rep. 2016;2016:bcr2016216686. doi:10.1136/bcr-2016-216686
  • Yoon H-J, Kyung Baek S, Lee W-I, et al. {JAK2} mutation-negative secondary erythrocytosis in multiple myeloma: a case report follow up. Exp. Hematol. 2013;41:S46. doi:10.1016/j.exphem.2013.05.181
  • Finazzi G, Gregg XT, Barbui T, et al. Idiopathic erythrocytosis and other non-clonal polycythemias. Best Pract Res Clin Haematol. 2006;19(3):471–482. doi:10.1016/j.beha.2005.07.006
  • Raaijmakers NJ, Bokma AHF, Eggen GG, et al. An unhealthy blush - secondary erythrocytosis due to waterpipe smoking. Neth J Med. 2020;78(4):202–205.
  • Keohane C, McMullin MF, Harrison C. The diagnosis and management of erythrocytosis. BMJ. 2013;347:f6667. doi:10.1136/bmj.f6667
  • Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin: a hormone with multiple functions. Pathobiology. 2011;78(1):41–53. doi:10.1159/000322975
  • Oymak O, Demiroğlu H, Akpolat T, et al. Increased erythropoietin response to venesection in erythrocytosic renal transplant patients. Int Urol Nephrol. 1995;27(2):223–227. doi:10.1007/BF02551324
  • Wille K, Sadjadian P, Griesshammer M. Differenzialdiagnose der Erythrozytose-Ursachen und klinische Bedeutung [Differential Diagnosis of Erythrocytosis-Background and Clinical Relevance]. Dtsch Med Wochenschr. 2019;144(2):128–135. German. doi:10.1055/a-0739-8340
  • Wilson R, Syed N, Shah P. Erythrocytosis due to PHD2 mutations: a review of clinical presentation, diagnosis, and genetics. Case Rep Hematol. 2016;2016:6373706. doi:10.1155/2016/6373706
  • Staszewski H. Hematological paraneoplastic syndromes. Semin Oncol. 1997;24(3):329–333.
  • Patnaik MM, Tefferi A. The complete evaluation of erythrocytosis: congenital and acquired. Leukemia. 2009;23(5):834–844. doi:10.1038/leu.2009.54
  • Sykes DB, Schroyens W, O’Connell C. The TEMPI syndrome--a novel multisystem disease. N Engl J Med. 2011;365(5):475–477. doi:10.1056/NEJMc1106670